Last week, the Financial Post reported that WuXi PharmaTech, China's largers drug research outsourcing company, is the latest Chinese company to make an American acquisition thus contributing to the trend in moving more and more drug development and production jobs to China. Moves such as this are being made to save time and money and Chinese CSOs are "expanding rapidly", according to the Post. My question is this: Considering recent scandals and tragic deaths stemming from the bioethics crisis and poor quality of pharmaceutical products coming out of China, does outsourcing to China by North American and European companies make any sense?
Sources:
Chinese drug firm granted FTC approval to acquire AppTec Laboratory. Financial Post. Thursday January 24, 2008.
